CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed
Drug / intervention
0-15 Waterdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00001783
NCT00001783Phase 2Completed

Neuroanatomical and Neurophysiological Basis of Motor Recovery Associated With Treatment of Recent Stroke Using Amphetamine and Physical Therapy

National Institute of Neurological Disorders and Stroke (NINDS)·interventional·Posted Nov 4, 1999·Updated Mar 4, 2008

In Brief

A Phase 2 clinical trial evaluating 0-15 Water for Cerebrovascular Accident and Paralysis. Completed, across 1 site.

Detailed Summary

The purpose of this study is to determine if giving amphetamines along with standard rehabilitation speeds motor recovery after a stroke. In addition, if motor recovery is improved, the study will also identify the areas of the brain involved with the recovery. Researchers will use motor function ratings, PET scans, functional MRI (fMRI), electroencephalographs, and transcranial magnetic stimulation (TMS) to evaluate patients. Patients participating in the study will be placed in one of two groups; 1. Patients receiving dextroamphetamine and routine Rehabilitation Medicine 2. Patients receiving a placebo "sugar pill" and routine Rehabilitation Medicine Patients that have improved motor recovery will undergo neuroimaging and neurophysiological studies to identify areas of the brain involved.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 4, 1999
Enrollment StartApr 1, 1998
Study CompletionJun 1, 2004
TodayJul 2, 2026
Posted 26.7 years ago

Interventions

0-15 Waterdrug